key: cord-0730647-u3zazdjo authors: Sahin, Dilek; Tanacan, Atakan; Erol, Seyit A.; Anuk, Ali T.; Yetiskin, Fatma D.Y.; Keskin, Huseyin L.; Ozcan, Namik; Ozgu‐Erdinc, A. Seval; Eyi, Elif G.Y.; Yucel, Aykan; Tayman, Cuneyt; Unlu, Serpil; Dinc, Bedia; Sari, Eyup; Surel, Aziz A.; Moraloglu, Ozlem T. title: Updated experience of a tertiary pandemic center on 533 pregnant women with COVID‐19 infection: A prospective cohort study from Turkey date: 2020-12-12 journal: Int J Gynaecol Obstet DOI: 10.1002/ijgo.13460 sha: 6201631a829499f967654469f3576a49662b7413 doc_id: 730647 cord_uid: u3zazdjo OBJECTIVE: To investigate the clinical course and impact of coronavirus disease 2019 (COVID‐19) infection on pregnant women. METHODS: A prospective cohort study was conducted on pregnant women with confirmed COVID‐19 infection. Demographic features, clinical characteristics, and perinatal outcomes were prospectively evaluated. RESULTS: Of the 533 cases, 161 (30.2%) had co‐morbidities and 165 (30.9%) were asymptomatic. Cough (n = 178, 33.4%) and myalgia (n = 168, 31.5%) were the leading symptoms. In total, 261 patients (48.9%) received COVID‐19 therapy, 509 (95.5%) had mild disease, 7 (1.3%) were admitted to the intensive care unit (ICU), and invasive mechanical ventilation was necessary in 2 (0.4%) patients. Maternal mortality was observed in 2 (0.4%) cases. Of the patients, 297 (55.7%) were hospitalized, 39 (7.3%) had suspicious radiologic imaging findings, 66 (12.4) had pregnancy complications (preterm delivery [n =22, 4.1%] and miscarriage [n =12, 2.2%] were the most common pregnancy complications), 131 births occurred, and the cesarean section rate was 66.4%. All neonates were negative for COVID‐19. The rate of admission to the neonatal ICU was 9.9%. One specimen of breast milk was positive for the infection. CONCLUSION: The course of COVID‐19 was mild in the majority of cases. However, increased rates of pregnancy complications and cesarean delivery were observed. Informed consent was obtained from all patients and the study protocol was approved by both the institutional ethics committee and the Turkish Ministry of Health (E1-20-602). The present study is an updated version of the previously published research by Sahin et al. 4 A precise diagnosis of COVID-19 infection was made by the detection of SARS-CoV-2 positivity on RT-PCR analysis of nasopharyngeal and oropharyngeal specimens collected from the participants. 4 The following information was prospectively recorded by the researchers: maternal age; gravidity; parity; number of living children; previous miscarriages; pre-pregnancy body mass index (BMI, calculated as weight in kilograms divided by the square of height in meters; BMI ≥30 was defined as obese); route of admission to hospital; co-morbid diseases; gestational age at diagnosis; pregnancy trimester at diagnosis; initial symptoms; close contact with a confirmed or suspected case; abnormal vital signs at admission; medications for pregnancy complications; COVID-19-related medications; disease severity; respiratory support; admission to the intensive care unit (ICU); maternal mortality; hospitalization rate; length of hospital stay; initial laboratory test results; radiologic imaging findings; blood group; pregnancy complications; mode of delivery; and obstetric and neonatal outcomes. All cases were managed according to the national guidelines at the time of the study by a multidisciplinary team comprising obstetricians, perinatologists, radiologists, neonatologists, and infectious disease specialists. 5 Statistical analyses were performed using SPSS version 22 (IBM Corp.). Mean or median values were used for descriptive variables according to the characteristics of the data. Categorical data were presented as numbers and percentages. During the study period, 533 pregnancies diagnosed with COVID-19 infection were followed up in the study institution. Demographic features and clinical characteristics of the cases are shown in Table 1 . A total of 161 (30.2%) cases had co-morbidities, of which obesity was the leading one (n = 71, 44.1%). A total of 238 (44.7%) cases were diagnosed in the third trimester. One hundred and sixty-five cases (30.9%) were asymptomatic. Cough (n = 178, 33.4%) and myalgia (n = 168, 31.5%) were the leading symptoms. One hundred and twenty-eight patients (24.1%) had close contact with a confirmed or suspected case. Tachycardia (n = 150, 28.1%) and fever (n = 71, 13.3%) were the most common abnormal vital signs. Thirty-three patients (6.2%) received pregnancy-specific medications. Tocolytic agents and antenatal corticosteroids were administered in 9 (1.7%) and 24 (4.5%) cases, respectively. Two hundred and sixty-one patients (48.9%) received COVID-19 therapy. Low-molecular weight heparin was administered in 220 (41.3%) cases. Hydroxychloroquine was the most common (10.3%) and tocilizumab was the least common (0.2%) administered medication. The vast majority of the patients had mild disease (n = 509, 95.5%). Seven cases (1.3%) were admitted to the ICU and invasive mechanical ventilation was necessitated in 2 (0.4%) patients. Respiratory support was given to 22 (4.1%) patients and 2 (0.4%) were intubated. Maternal mortality was observed in 2 (0.4%) cases. The first case of maternal mortality was a 27-year-old primigravida at 18 weeks of pregnancy who was admitted to hospital via ambulance for RT- Ground-glass opacifications, mixed consolidations, pleural/interlobular septal thickening, and air bronchograms were the most common radiologic findings in previous studies. 18 The findings of the present study were mostly consistent with the current literature. However, although they were measured in only 15% of cases, mean lipid levels were within normal limits. Another important point is the association between electrolyte imbalance and poor outcome in COVID-19. 19 The strengths of the present study were the prospective design, high number of study parameters, and the single-center experience. However, a lack of information related to the final outcomes of ongoing pregnancies is the main limitation. In conclusion, the course of COVID-19 was mild in the majority of cases at Ankara City Hospital. However, increased rates of pregnancy complications and cesarean section were observed. There were no cases of vertical transmission. The authors thank Dr Sophia NE Webster, MRCOG, for revising the article as a native English speaker. Additionally, they give special thanks to all the healthcare staff at the hospital, who work devotedly for the health of the community during the pandemic period. The authors have no conflicts of interest. A novel coronavirus from patients with pneumonia in China Clinical characteristics, prognostic factors, and maternal and neonatal outcomes of SARS-CoV-2 infection among hospitalized pregnant women: a systematic review Maternal and neonatal characteristics and outcomes among COVID-19 infected women: An updated systematic review and meta-analysis A pandemic center's experience of managing pregnant women with COVID-19 infection in Turkey: A prospective cohort study Turkish Ministry of Health, General Directorate of Public Health, COVİD-19 (SARS-CoV-2 infection) Guideline, Scientific Committee Report ISUOG Interim Guidance on 2019 novel coronavirus infection during pregnancy and puerperium: information for healthcare professionals Coronavirus disease 2019 (COVID-19) and pregnancy: what obstetricians need to know Characteristics of and important lessons from the Coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention The relationship between status at presentation and outcomes among pregnant women with COVID-19 COVID-19 infection among asymptomatic and symptomatic pregnant women: Two weeks of confirmed presentations to an affiliated pair of Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study Management of pregnant women infected with COVID-19 ISTH interim guidance on recognition and management of coagulopathy in COVID-19 Use of remdesivir for pregnant patients with severe novel coronavirus disease 2019 The tragedy of COVID-19 in Brazil: 124 maternal deaths and counting COVID-19 and maternal, fetal and neonatal mortality: a systematic review Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis Electrolyte imbalances in patients with severe coronavirus disease 2019 (COVID-19) Relationship between ABO blood group distribution and clinical characteristics in patients with COVID-19 Late miscarriage as a presenting manifestation of COVID-19 COVID-19 unlikely to cause birth defects, but doctors await fall births Vertical transmission of COVID-19: a systematic review and meta-analysis Neonatal management and outcomes during the COVID-19 pandemic: an observation cohort study Promotion of scientific research on COVID-19 in Turkey Updated experience of a tertiary pandemic center on 533 pregnant women with COVID-19 infection: A prospective cohort study from Turkey